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Betulinic acid (BA) is a pentaciclic triterpene, exhibiting strong cytotoxic activity but low water 
solubility, which affects its bioavailability and biological activity. Extensive studies have been 
carried out for increasing the solubility and bioavailability of BA, one option being BA-
bioconjugates with gold nanoparticles (GNP). The synthesis of BA GNP bioconjugates was 
achieved by using cysteamine as a linker between the organic molecule and the metallic 
surface of GNP. BA’s carboxylic group was condensed to the amine group of cysteamine using 
DCC and DMAP in dichlormethane. The completion of the reaction was monitored by means 
of TLC. The obtained BA amide was purified by flash column chromatography. FT-IR and LC-
MS analysis confirmed the identity of the synthesized compound. Synthesis of GNPs was 
conducted accordingto a previously published procedure. The synthesis is achieved by 
reducing chloroauric acid (HAuCl4) withtrisodium citrate dihydrate (C6H5O7Na3∙2H2O) using a 
HAuCl4:C6H5O7Na3molar ratio of 1:3.5. The obtained clear ruby-redsolution was cooled at 
room temperature. Purificationwas accomplished by repeated steps involving 
centrifugationfollowed by washing with deionized water. The finalproduct was lyophilized and 
resuspended in methanol. A methanolic solution of BA-cysteamine amide was added drop 
wise to the methanolic suspension of GNPs, under continuous stirring for 24h, allowing the 
thiol group to attach to the metallic surface. After the completion of the reaction, methanol 
was slowly evaporated under reduced pressure and the obtained formulation was washed 
with deionized water, centrifuged and lyophilized. The obtained product was refrigerated. This 
current nanoformulation will be further investigated for its proposed anticancer activity.  
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